iifl-logo

Alkem Laboratories Ltd Share Price

4,835.55
(-0.95%)
Apr 1, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open4,889.95
  • Day's High4,950
  • 52 Wk High6,439.9
  • Prev. Close4,881.7
  • Day's Low4,804.55
  • 52 Wk Low 4,407.05
  • Turnover (lac)1,588.57
  • P/E26.09
  • Face Value2
  • Book Value1,050.35
  • EPS187.04
  • Mkt. Cap (Cr.)57,816.25
  • Div. Yield0.82
View All Historical Data

Alkem Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

4,889.95

Prev. Close

4,881.7

Turnover(Lac.)

1,588.57

Day's High

4,950

Day's Low

4,804.55

52 Week's High

6,439.9

52 Week's Low

4,407.05

Book Value

1,050.35

Face Value

2

Mkt Cap (₹ Cr.)

57,816.25

P/E

26.09

EPS

187.04

Divi. Yield

0.82

Alkem Laboratories Ltd Corporate Action

29 May 2024

12:00 AM

AGM

Announcement Date: 29 May, 2024

arrow

29 May 2024

12:00 AM

Dividend

Dividend Amount: 5

Record Date: 10 Aug, 2024

arrow

28 Jan 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Alkem Laboratories Ltd NEWS AND UPDATE

Alkem Labs' Taloja Bioequivalence Center Clears USFDA Inspection
16 Mar 2025|10:04 PM

This inspection, conducted from March 10 through March 13, 2025, was to evaluate compliance with the legal standards concerning bioequivalence studies.

Read More
Alkem Laboratories Q3 Profit Rises 5% YoY
9 Feb 2025|10:44 PM

The company saw its revenues increase by 1.5% YoY at ₹3,374 crore from ₹3,324 crore.

Read More
Alkem Launches Kojiglo Serum in India for Hyperpigmentation Treatment
5 Feb 2025|11:24 AM

The serum contains liposomal azelaic acid, liposomal 4-butyl resorcinol, tranexamic acid, alpha arbutin, and niacinamide.

Read More
Alkem Labs Q2 Profit Rises 11% to ₹689 Crore
14 Nov 2024|01:38 PM

R&D expenses rose to ₹146.5 crore, making up 4.3% of total revenue, compared to ₹115.8 crore (3.4% of revenue) in the previous year.

Read More
Cipla, Alkem Vie for SMT Acquisition
16 Oct 2024|11:29 AM

This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Alkem Laboratories Ltd SHAREHOLDING SNAPSHOT

02 Apr, 2025|07:13 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 55.66%

Foreign: 0.00%

Indian: 55.66%

Non-Promoter- 28.15%

Institutions: 28.15%

Non-Institutions: 16.17%

Custodian: 0.00%

Share Price

Alkem Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

23.91

23.91

23.91

23.91

Preference Capital

0

0

0

0

Reserves

10,530.7

9,325.94

8,719.75

7,601.84

Net Worth

10,554.61

9,349.85

8,743.66

7,625.75

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

8,829.81

7,219.68

6,677.08

5,300.26

yoy growth (%)

22.3

8.12

25.97

16.53

Raw materials

-3,565.89

-2,665.02

-2,550.56

-2,075.22

As % of sales

40.38

36.91

38.19

39.15

Employee costs

-1,434.49

-1,158.72

-1,066.76

-861.63

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

1,753.37

1,897.08

1,338.08

934.29

Depreciation

-218.98

-198.93

-186.84

-107.65

Tax paid

-212.12

-199.22

-73.66

-218.45

Working capital

954.38

1,212.29

1,245.84

514.21

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

22.3

8.12

25.97

16.53

Op profit growth

-7.11

32.79

47.85

13.05

EBIT growth

-7.66

40.9

42.42

5.28

Net profit growth

-8.53

33.26

76.63

-18.94

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

12,667.58

11,599.26

10,634.19

8,865.01

8,344.36

Excise Duty

0

0

0

0

0

Net Sales

12,667.58

11,599.26

10,634.19

8,865.01

8,344.36

Other Operating Income

0

0

0

0

0

Other Income

310.84

216.08

162.65

233.21

104.22

Alkem Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,698.35

129.244,07,155.151,181.050.85,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,549.7

71.051,47,295.245940.542,297513.62

Cipla Ltd

CIPLA

1,444.25

25.071,16,664.331,438.150.94,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183.9

59.031,07,673.274850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,458.1

52.421,01,358.17416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Alkem Laboratories Ltd

Management

Register Office

Registrar Office

Executive Chairman

Basudeo N Singh

Managing Director

SANDEEP SINGH

Executive Director

Mritunjay Kumar Singh

Non-Exec. & Independent Dir.

A K Purwar

Non-Exec. & Independent Dir.

SANGEETA KAPILJIT SINGH

Non-Exec. & Independent Dir.

SUDHA RAVI

Company Sec. & Compli. Officer

Manish Narang

Non-Exec. & Independent Dir.

Narendra Aneja

Executive Director

SARVESH SINGH

Executive Director

Madhurima Singh

Independent Director

Sujjain Talwar

Executive Director

Srinivas Singh

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales. The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Ltd was incorporated as a private limited company on August 8, 1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988. Pursuant to Company passing a resolution under section 21 of Companies Act, 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21, 2001, the name of Company was changed to Alkem Laboratories Limited with effect from October 26, 1988.In 1978, the company established its first plant at Taloja Maharashtra. In 1992, the company established its manufacturing facility in Mandwa, Maharashtra, which was later converted into an API facility in 2005. In 2003, the company set up a research and development facility for ANDA development
Read More

Company FAQs

What is the Alkem Laboratories Ltd share price today?

The Alkem Laboratories Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹4835.55 today.

What is the Market Cap of Alkem Laboratories Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alkem Laboratories Ltd is ₹57816.25 Cr. as of 01 Apr ‘25

What is the PE and PB ratio of Alkem Laboratories Ltd?

The PE and PB ratios of Alkem Laboratories Ltd is 26.09 and 4.96 as of 01 Apr ‘25

What is the 52 Week High and Low of Alkem Laboratories Ltd?

The 52-week high/low is the highest and lowest price at which a Alkem Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Alkem Laboratories Ltd is ₹4407.05 and ₹6439.9 as of 01 Apr ‘25

What is the CAGR of Alkem Laboratories Ltd?

Alkem Laboratories Ltd's CAGR for 5 Years at 16.33%, 3 Years at 11.45%, 1 Year at -3.46%, 6 Month at -21.39%, 3 Month at -13.20% and 1 Month at 5.11%.

What is the shareholding pattern of Alkem Laboratories Ltd?

The shareholding pattern of Alkem Laboratories Ltd is as follows:
Promoters - 55.66 %
Institutions - 28.16 %
Public - 16.18 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.